Literature DB >> 22158598

Kidney cancer in 2011: objectifying risk for localized renal masses.

Marc C Smaldone1, Robert G Uzzo.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22158598     DOI： 10.1038/nrurol.2011.195

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

2.  Guideline for management of the clinical T1 renal mass.

Authors:  Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 3.  Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

Authors:  Marc C Smaldone; Alexander Kutikov; Brian L Egleston; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Michael A Jewett; Richard E Greenberg; Robert G Uzzo
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

4.  Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy.

Authors:  Jay Simhan; Marc C Smaldone; Kevin J Tsai; Daniel J Canter; Tianyu Li; Alexander Kutikov; Rosalia Viterbo; David Y T Chen; Richard E Greenberg; Robert G Uzzo
Journal:  Eur Urol       Date:  2011-05-25       Impact factor: 20.096

5.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

Review 6.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

7.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer.

Authors:  Michael A S Jewett; Kamal Mattar; Joan Basiuk; Christopher G Morash; Stephen E Pautler; D Robert Siemens; Simon Tanguay; Ricardo A Rendon; Martin E Gleave; Darrel E Drachenberg; Raymond Chow; Hannah Chung; Joseph L Chin; Neil E Fleshner; Andrew J Evans; Brenda L Gallie; Masoom A Haider; John R Kachura; Ghada Kurban; Kimberly Fernandes; Antonio Finelli
Journal:  Eur Urol       Date:  2011-04-01       Impact factor: 20.096

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

9.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.

Authors:  Alexander Kutikov; Robert G Uzzo
Journal:  J Urol       Date:  2009-07-17       Impact factor: 7.450

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969
  10 in total
  1 in total

1.  PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.

Authors:  Alexander W MacFarlane; Mowafaq Jillab; Elizabeth R Plimack; Gary R Hudes; Robert G Uzzo; Samuel Litwin; Essel Dulaimi; Tahseen Al-Saleem; Kerry S Campbell
Journal:  Cancer Immunol Res       Date:  2013-11-25       Impact factor: 11.151
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.